Login
Israel-Hamas Conflict
Independence Day
Floods
World Cup
Natural Disasters
Social Media
South America
Real Madrid
Artificial Intelligence
Soccer
Donald Trump
BRICS
Parade
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

High Tumor Volume Confers CAR T-Cell Therapy Toxicity Risk in LBCL

Summary by cancernetwork.com
Data support incorporating volumetric PET biomarkers into toxicity risk prediction for patients receiving CAR T-cell therapy for LBCL.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
oncnursingnews.comoncnursingnews.com

High Tumor Volume Linked to CAR T Toxicity in LBCL

Volumetric PET biomarkers may help predict risk of toxicity from CAR T-cell therapy in patients with large B-cell lymphoma, new retrospective data suggest.

Read Full Article
cancernetwork.comcancernetwork.com

High Tumor Volume Confers CAR T-Cell Therapy Toxicity Risk in LBCL

Data support incorporating volumetric PET biomarkers into toxicity risk prediction for patients receiving CAR T-cell therapy for LBCL.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

cancernetwork.com broke the news in on Monday, June 30, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal